Find out if you’re eligible for Microdose GLP-1Rx
What is your weight loss goal?
Microdose: The Easy Way to Start a GLP-1
Noom Microdose GLP‑1Rx Program helps you lose weight and get healthy.
- Personalized: Microdose Compounded Semaglutide and Tirzepatide offerings
- Limited Time Offer: Plans start at $49 1 and include medication
- Friendly: A gentle start to weight loss
Paired with behavior change and coaching–for results that last.
Why Noom Microdose?
Plans start at just $491
Affordable care that provides real results, including meds, clinical visits, and ongoing support
Lose up to 17 pounds in 60 days2
Lose weight comfortably with dosing tailored to your body and pace.
Behavior change and coaching
Get access to Noom GLP-1 Companion for extra support
A low dose doesn’t mean low weight loss
We found our members lost up to 9 pounds in just 30 days.2
How it Works
-
1
Take a brief intake survey
Share your health history and weight-loss goals and receive your clinical plan.
-
2
Connect with an expert clinician
A clinician will quickly evaluate your results and provide a prescription all online, if clinically appropriate.
-
3
Start losing weight with your customized Microdose plan
Get medication shipped, if eligible, and begin your journey with the lowest effective dose that delivers results.3
-
4
Ongoing care and medication
Receive continuous monitoring and adjustments, with unlimited access to your clinician and medication refills, where clinically appropriate.
Success Stories
“My medication has removed my cravings for sugar. I am down 16 pounds.”
“Noom provided me with the medication which I could not get through Medicare. I have learned the tricks to better eating and life in general."
Read More About GLP-1s
Frequently Asked Questions
1Initial 3 week subscription and 4 weeks of medication from $49 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. Compounded semaglutide available through Noom-GLP1ᴿˣ is produced in an FDA-registered facility but has not been reviewed by the FDA for safety, efficacy, or quality. Be sure to discuss any concerns with your Noom Med clinician before starting treatment. No affiliation with Novo Nordisk, Inc., the only US source of FDA-approved semaglutide. No affiliation with Eli Lilly and Company, the only US source of FDA-approved tirzepatide. Not available in all 50 states. New pricing for new accounts only effective as of July 27, 2026.
2 Results obtained from a study of 3,562 Noom users self-reported data with at least 27 bmi. Average expected weight loss for those who followed the titration protocol was 5.8 lbs.
3 Not all medications are available for home delivery. Availability of home delivery will depend on your insurance or cash pay status. If your clinician feels compounded medications are clinically appropriate for you, any compounded medications are not approved by the FDA or reviewed for quality, safety or efficacy. Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic® and Wegovy®. Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide identified under the trade names Zepbound® and Mounjaro®
